Nissay Capital
VC Fund
Tokyo, Japan
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
- Total investments:
- 264
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Nissay Capital invests in
Stages Nissay Capital invests in
Countries Nissay Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Seed
- $565k–$43M
- Series A
- $2M–$71M
Investment Focus
Industry
- Health Care 27 (10%)
- Information Technology 21 (8%)
- Medical 19 (7%)
- Internet 18 (7%)
- Software 17 (6%)
Stage
- Funding Round 65 (25%)
- Seed 56 (21%)
- Series A 44 (17%)
- Series B 37 (14%)
- Series C 8 (3%)
Country
- Japan 181 (69%)
- United States 2 (1%)
- Ethiopia 1 (0%)
- Indonesia 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Eiji Arima
President and CEO
|
President and CEO | Total investments: 2 | Find email | |
|
Ito Shun
Senior Capitalist
|
Senior Capitalist | Total investments: 3 | Find email | |
|
Kenko Nagai
Capitalist
|
Capitalist | Total investments: 5 | Find email | |
|
Natsuki Fujiki
Investment Department Capitalist
|
Investment Department Capitalist | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
GTN is a Japanese real estate brokerage firm. Foreigners can use the company's rent guarantee and real estate rental brokerage services to acquire brokerage services at a low cost. | $18.5M / Private Equity / Jul 21, 2026 | |
|
|
Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses. | $32.8M / Series B / Jun 30, 2026 | |
|
|
Styz is a non-profit service platform that creates money flow and socially inclusive design methods for new and existing businesses. | $1.7M / Series A / Jun 25, 2026 | |
|
|
ElevationSpace offers high quality & well equipped workspaces giving tenants a nurturing environment . | $39.7M / Series B / Jun 19, 2026 | |
|
|
Direava is a medical device company that manufactures, sells, leases, and maintains medical equipments along with consulting services. | Venture - Series Unknown / Jun 04, 2026 | |
|
|
Direava is a medical device company that manufactures, sells, leases, and maintains medical equipments along with consulting services. | Venture - Series Unknown / Jun 04, 2026 | |
|
|
MENOU specializes in AI technology and sensing technology. It features a graphical image identification modeler software. | $3.3M / Series B / Jun 01, 2026 | |
|
|
Movus Technologies Indonesia is automotive company that provides car ownership rental services. | $10.5M / Series B / May 15, 2026 | |
|
|
Fogg is a platform that makes life styles more convenient without being affected by trends and deprecation like media and content | $1.9M / Series B / Apr 30, 2026 | |
|
|
Qubitcore is a pioneering startup founded with the mission of commercializing and advancing the research outcomes of the Quantum Information Physics Experimental Unit, focusing on the practical implementation of quantum technologies in computing, communication, and information processing. | $9.6M / Seed / Apr 27, 2026 | |
| See all 264 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Nissay Capital invest in?
Nissay Capital invests primarily in Health Care, Information Technology and Medical startups, most often at Funding Round and Seed stage. Most of the 264 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Nissay Capital's check size?
Nissay Capital typically joins rounds of $565k–$43M at Seed and $2M–$71M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Nissay Capital participates in.
How do I contact Nissay Capital?
Public channels for Nissay Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Nissay Capital?
The team at Nissay Capital includes Eiji Arima (President and CEO), Ito Shun (Senior Capitalist) and Kenko Nagai (Capitalist). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!